| Original language | English |
|---|---|
| Pages (from-to) | 1161 |
| Number of pages | 1 |
| Journal | New England Journal of Medicine |
| Volume | 371 |
| Issue number | 12 |
| Publication status | Published - 2014 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Dalbavancin or oritavancin for skin infections.
Research output: Contribution to a Journal (Peer & Non Peer) › Comment/debate
1
Citation
(Scopus)